2015 Taubman Prize Selection Committee Members

The following individuals comprise the national selection committee that will judge the entries for the 2015 Taubman Prize:

Valerie Castle, M.D.

  • Chair, Pediatrics and Communicable Diseases, University of Michigan Medical School
  • Ravitz Foundation Professor of Pediatrics and Communicable Diseases
  • Professor of Pediatric Hematology/Oncology

 

Harry Dietz, M.D.

  • Victor A. McKusick Professor of Genetics and Medicine, Johns Hopkins University
  • Howard Huges Medical Institute Investigator
  • 2012 Taubman Prize recipient

 

Carl H. June, M.D.

  • Richard W. Vague Professor in Immunotherapy, Perelman School of Medicine, University of Pennsylvania
  • 2014 Taubman Prize recipient

 

Gary Koretzky, M.D., Ph.D.

  • Dean, Weill Cornell Graduate School, Cornell University
  • Senior Associate Dean for Research and Professor, Weill Cornell Medical College
  • Frank H.T. Rhodes Distinguished Professor in Cardiovascular Biology and Genetics

 

William C. Mobley, M.D., Ph.D.

  • Distinguished Professor and Chair, Department of Neurosciences, University of California at San Diego
  • Executive Director, UCSD Down Syndrome Center for Research and Treatment 
  • Florence Riford Chair of Alzheimer Disease Research

 

Elizabeth G. Nabel, M.D.

  • President, Brigham and Women’s / Faulkner Hospitals

 

David C. Page, M.D.

  • Director, Whitehead Institute
  • Professor of Biology, Massachusetts Institute of Technology
  • Howard Hughes Medical Institute Investigator

 

Charles L. Sawyers,  M.D.

  • Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
  • Marie-Josee and Henry R. Kravis Chair
  • Howard Hughes Medical Institute Investigator
  • 2013 Taubman Prize recipient

 

Stephen M. Strittmatter, M.D., Ph.D.

  • Vincent Coates Professor of Neurology and Professor of Neurobiology, Yale School of Medicine
  • Director, Cellular Neuroscience, Neurodegeneration and Repair
  • Director, Memory Disorder

 

Barbara Vickrey, M.D., M.P.H.

  • President and Vice Chair, Department of Neurology, David Geffen School of Medicine, University of California at Los Angeles

 

Tachi Yamada, M.D.

  • Executive Vice President, Chief Medical and Scientific Officer
  • Takeda Pharmaceutical Co.


 

 

 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists